SOX2 and cancer: In AR inhibitor-resistant cells, H3K27ac enrichment at TWIST1 enhancers sustains mesenchymal traits (Chen et al., 2022), while dynamic H3K4me3 modifications at stemness-related genes (SOX2) couple EMT with cancer stem cell properties (Mitchell et al., 2023).